Compare BMRN & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMRN | PNFP |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | 3595 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.5B |
| IPO Year | 1999 | N/A |
| Metric | BMRN | PNFP |
|---|---|---|
| Price | $55.50 | $87.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 16 |
| Target Price | $88.22 | ★ $110.87 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $14.30 | $163.66 |
| Revenue Next Year | $11.65 | $7.77 |
| P/E Ratio | $30.84 | ★ $12.24 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $50.76 | $81.08 |
| 52 Week High | $66.28 | $120.39 |
| Indicator | BMRN | PNFP |
|---|---|---|
| Relative Strength Index (RSI) | 43.52 | 50.76 |
| Support Level | $54.67 | $83.62 |
| Resistance Level | $56.21 | $89.29 |
| Average True Range (ATR) | 1.54 | 2.10 |
| MACD | 0.07 | 0.88 |
| Stochastic Oscillator | 39.36 | 86.76 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.